Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab-paclitaxel|DRUG: trastuzumab|DRUG: Doxorubicin|DRUG: cyclophosphamide|BIOLOGICAL: Growth Factor Support|PROCEDURE: Surgery
Sponsor: University of Kansas Medical Center
Collaborators: Celgene Corporation